Criscitiello, C <br/><br/>
Factors affecting surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Apr 2014 
 - 910-911 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdu034  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Breast Neoplasms--drug therapy<br/>Female<br/>Humans<br/>Mastectomy, Segmental<br/>Neoadjuvant Therapy<br/>Receptor, ErbB-2--metabolism